# 2026-12237: FDA Tinkers With Animal Feed Record Rules

2026-12237, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Regulations for Type A Medicated Articles and Medicated Feeds, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-06-18, effective Submit written comments (including recommendations) on the collection of information by July 20, 2026.; PRIA reads it as touching household money (as of 2026-06-25).

- Canonical: https://policyrisk.com/federal-register/2026-12237
- As of: 2026-06-25
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-12237
- Title: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Regulations for Type A Medicated Articles and Medicated Feeds
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 36863
- Published: 2026-06-18
- Effective: Submit written comments (including recommendations) on the collection of information by July 20, 2026.
- Comments close: 2026-07-20
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-25

## In one line

FDA Tinkers With Animal Feed Record Rules

## Summary

The FDA is updating how companies that make special animal medicines and feeds keep their records and follow quality rules. This affects manufacturers of Type A medicated articles and medicated feeds, helping ensure safe and reliable products for animals. Comments on these changes are open until July 20, 2026, and the updates aim to keep things clear without adding extra costs.

## Abstract

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

## Effects PRIA read

- OMB Collections Consolidated into 0910-0152: benefit, low. The FDA is consolidating reporting for current good manufacturing practices (CGMPs) for Type A medicated articles and medicated feeds into one OMB control number (0910-0152) and will discontinue OMB control number 0910-0154. The agency requests public comments by July 20, 2026.
- Recordkeeping Burden: Registered Licensed Feed Mills: cost, high. Registered licensed commercial feed mills (768 respondents) have estimated total annual responses of 2,241,792 and an average burden of 0.305 hours (18.3 minutes) per response, for a total of 683,747 hours annually under 21 CFR part 225 recordkeeping requirements.
- Recordkeeping Burden: Non-licensed Commercial Feed Mills: cost, medium. Nonregistered, non-licensed commercial feed mills (1,658 recordkeepers) have an estimated 150,878 total annual records, an average burden of 1.44 hours per record, and a total of 217,265 recordkeeping hours annually under 21 CFR part 225.
- Recordkeeping Burden: Non-licensed Mixer/Feeders: cost, medium. Nonregistered, non-licensed mixer/feeders (3,400 respondents) are estimated to have 309,400 total annual disclosures with an average burden of 1.36 hours per disclosure, totaling 420,784 hours annually for recordkeeping under 21 CFR part 225.
- Recordkeeping Burden: Type A Medicated Article Manufacturers: cost, high. Manufacturers of Type A medicated articles (65 respondents) have an estimated 1,370 disclosures per respondent for a total of 89,050 annual disclosures and an average burden of about 1 hour per disclosure, totaling 89,050 hours annually under 21 CFR part 226.
- Net Reduction in Estimated Recordkeeping Burden: benefit, high. FDA updated its inventory and reduced the number of medicated feed mill recordkeepers by 2,722, which corresponds to a reduction of 13,731,017 records and a decrease of 913,153 recordkeeping hours in its estimates.

## Related documents

- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27
- [2026-20727](https://policyrisk.com/federal-register/2026-20727): Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorgani…, 2026-10-09

## Sources
- [2026-12237 on federalregister.gov](https://www.federalregister.gov/documents/2026/06/18/2026-12237/agency-information-collection-activities-submission-for-office-of-management-and-budget-review)
- [2026-12237 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-06-18/pdf/2026-12237.pdf)

## Related
- [Previous: 2026-12236, SpecGx LLC; Withdrawal of Approval of Abbreviated New Drug Application for Meth…](https://policyrisk.com/federal-register/2026-12236)
- [Next: 2026-12238, Agency Information Collection Activities; Submission for Office of Management a…](https://policyrisk.com/federal-register/2026-12238)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-12237 (as of 2026-06-25).